Psoriatic Arthritis (PsA)
Log out
to your PfizerFlex
Patient Support Program
for ABRILADA
Psoriatic Arthritis (PsA)
Psoriatic arthritis (PsA) is a disease in which the immune system mistakenly attacks healthy tissue, including the skin and joints.This leads to inflammation that triggers joint pain, stiffness, and swelling, as well as skin symptoms such as itchy and scaly rashes. About 30% of people with psoriasis develop PsA, but some people with PsA never develop psoriasis. PsA affects both men and women equally.
ABRILADA is used to treat adults with psoriatic arthritis (PsA).
Your immune system works to protect your body from bacteria, viruses, and other foreign agents. In PsA, the immune system mistakenly recognizes the body as foreign and attacks healthy body cells.
When you have PsA, your immune system overproduces a substance called TNF-alpha (which stands for tumour necrosis factor alpha). The extra TNF-alpha can attack normal healthy body tissues and cause inflammation, especially in the bones, cartilage, joints, and skin.
The way ABRILADA works is by binding to TNF-alpha and decreasing the inflammation process of PsA. However, ABRILADA can also lower the body’s ability to fight infections, and taking it can make you more prone to getting infections, or make any infection worse.
ABRILADA is administered by injection under the skin, also called a subcutaneous injection.
ABRILADA ®, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
PFIZERFLEX TM, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
© 2024 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5
PP-ABD-CAN-0037-EN
